IBRX
Immunitybio Inc
Price:  
2.87 
USD
Volume:  
8,811,134.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IBRX WACC - Weighted Average Cost of Capital

The WACC of Immunitybio Inc (IBRX) is 8.1%.

The Cost of Equity of Immunitybio Inc (IBRX) is 8.55%.
The Cost of Debt of Immunitybio Inc (IBRX) is 6.40%.

Range Selected
Cost of equity 7.30% - 9.80% 8.55%
Tax rate -% - -% -%
Cost of debt 5.80% - 7.00% 6.40%
WACC 7.0% - 9.3% 8.1%
WACC

IBRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.74 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.30% 9.80%
Tax rate -% -%
Debt/Equity ratio 0.24 0.24
Cost of debt 5.80% 7.00%
After-tax WACC 7.0% 9.3%
Selected WACC 8.1%